EP. 1: Molecular Testing in Patients With NSCLC
Watch
EP. 2: Next-Generation Sequencing in Patients With NSCLC
EP. 3: Nondriver NSCLC Treatment Factors
EP. 4: Nondriver NSCLC Trials: KEYNOTE-189, -407, -024
EP. 5: NSCLC Treatment: Low PD-L1 Status and Chemotherapy
EP. 6: Metastatic NSCLC I-O Combination Therapies
EP. 7: Combination I-O Treatment Factors & Preference
EP. 8: Pembrolizumab for Relapsed/Refractory Metastatic NSCLC
EP. 9: The REVEL Trial and Subanalysis
EP. 10: Ramucirumab for Relapsed-Refractory Metastatic NSCLC
EP. 11: The Impact of <i>EGFR</i> TKI on Nonsquamous NSCLC
EP. 12: ALK Inhibitors and BRAF/MEK Inhibitors for NSCLC
EP. 13: The Changing Landscape of NSCLC Clinical Care